Stevens-Johnson syndrome

Area of Science:

• Dermatology
• Pharmacology
• Oncology

Background:

• Stevens-Johnson Syndrome (SJS) is a severe adverse cutaneous drug reaction.
• It can be triggered by medications such as phenytoin and topical nitrogen mustard.
• Concurrent administration of phenytoin and steroids during cranial irradiation increases SJS risk.

Purpose of the Study:

• To highlight the critical nature of Stevens-Johnson Syndrome.
• To emphasize the importance of prompt recognition and medication withdrawal in SJS management.
• To underscore the role of nurses in patient assessment and education regarding SJS.

Main Methods:

• Literature review on SJS.
• Analysis of risk factors associated with SJS.
• Discussion of clinical presentation and management strategies.

Main Results:

• SJS presents with symptoms including headache, malaise, fever, and mucocutaneous sloughing.
• Prompt identification and cessation of the causative agent are vital for treatment.
• Nurses are essential in identifying SJS signs and symptoms.

Conclusions:

• Early recognition and withdrawal of offending medications are paramount in managing Stevens-Johnson Syndrome.
• Nurses are integral to the early detection and patient education for SJS.
• Understanding risk factors like concurrent cranial irradiation therapy is important.